Cost impact of trastuzumab prescribing in the treatment of advanced Her2 positive gastric cancer in Ireland
| Data(s) |
2012
|
|---|---|
| Identificador | |
| Publicador |
Springer U K |
| Relação |
http://www.scopus.com/inward/record.url?eid=2-s2.0-84866732328&partnerID=40&md5=4e24bb35ca028c52ae35cadfcf023fae DOI:10.1007/s11845-011-0772-7 Collins, Ian M., King, F., & O'Byrne, Kenneth J. (2012) Cost impact of trastuzumab prescribing in the treatment of advanced Her2 positive gastric cancer in Ireland. Irish Journal of Medical Science, 181(3), pp. 451-452. |
| Direitos |
Copyright 2012 Springer U K |
| Fonte |
School of Biomedical Sciences; Faculty of Health; Institute of Health and Biomedical Innovation |
| Palavras-Chave | #antineoplastic agent #epidermal growth factor receptor 2 #trastuzumab #drug cost #esophagus cancer #gene amplification #health care delivery #human #immunohistochemistry #Ireland #letter #major clinical study #overall survival #quality of life #stomach cancer #Antibodies #Monoclonal #Humanized #Antineoplastic Agents #Esophageal Neoplasms #Humans #Quality-Adjusted Life Years #Receptor #erbB-2 #Stomach Neoplasms |
| Tipo |
Journal Article |
